ACMG Mulls Minimum Gene List for Returning Secondary Findings from Clinical WGS | GenomeWeb

By Monica Heger

A workgroup of the American College of Medical Genetics is devising guidelines to address issues related to returning secondary findings from clinical whole-exome and whole-genome sequencing studies.

Among the considerations is identifying a minimum list of genes for which information on variants should be returned — even when these genes are not implicated in the disease for which the sequencing was conducted.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.